Unlocking Legalities: False-Claim Standards Continue To Evolve
Executive Summary
The finer points of when exactly the US government can collect from a device company for selling it a bill of goods are under reconsideration, even as the fast pace of False Claims Act suits continues, attorneys with law firm Gibson Dunn concluded during a series of recent webinars.
You may also be interested in...
Shire To Pay Record-Setting Device FCA Settlement
The $350m settlement resolves False Claims Act allegations Shire and its subsidiaries used tactics including lavish meals, free medical equipment, unearned speaker payments and cash to encourage doctors to prescribe the company’s Dermagraft human skin substitute.
FCA Liability After Escobar: Challenges And Opportunities For Device Companies
A recent Supreme Court decision addressing the False Claims Act holds important implications for medical device companies, according to Gibson Dunn attorneys John D. W. Partridge, Jonathan M. Phillips and Reid F. Rector in this guest column.
Olympus Pays Record Anti-Kickback Penalty For Device Case
Olympus Corp. is making a record payment and implementing stricter internal compliance controls and monitoring to avoid prosecution on kickback allegations.